Jens Sören Worthmann

Title: Jens Sören Worthmann: Innovator in Pharmaceutical Compositions

Introduction

Jens Sören Worthmann is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions involving lipoic acid choline ester salts. With a total of 2 patents to his name, Worthmann's work is recognized for its potential impact on medical treatments.

Latest Patents

Worthmann's latest patents focus on pharmaceutical compositions of lipoic acid choline ester salts and methods of treatment using these compositions. The disclosures provide salts of lipoic acid choline ester (LACE), along with crystalline forms and methods of use. These innovations aim to enhance the efficacy of treatments involving LACE salts, showcasing Worthmann's commitment to advancing pharmaceutical science.

Career Highlights

Jens Sören Worthmann is currently associated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to collaborate with other experts in the field and contribute to groundbreaking research and development in pharmaceuticals. His work is characterized by a focus on improving health outcomes through innovative drug formulations.

Collaborations

Throughout his career, Worthmann has worked alongside esteemed colleagues such as Christoph Bucher and Dietmar Flubacher. These collaborations have fostered a dynamic environment for innovation and have played a crucial role in the advancement of their shared research goals.

Conclusion

Jens Sören Worthmann stands out as a significant figure in the pharmaceutical industry, with his innovative patents and collaborations contributing to the advancement of medical treatments. His work continues to inspire future developments in the field.